User:Mr. Ibrahem/Erenumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | CGRPR |
Clinical data | |
Trade names | Aimovig |
Other names | AMG-334, erenumab-aooe |
AHFS/Drugs.com | Monograph |
MedlinePlus | a618029 |
License data | |
Pregnancy category |
|
Routes of administration | Subcutaneous injection |
Drug class | CGRPR blocker[2] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 82% (estimated) |
Metabolism | Proteolysis |
Elimination half-life | 28 days |
Chemical and physical data | |
Formula | C6472H9964N1728O2018S50 |
Molar mass | 145871.98 g·mol−1 |
Erenumab, sold under the brand name Aimovig, is a medication used to prevent migraine headaches.[3] It is used in those who have at least 4 headaches a month.[4] It is given by injection under the skin.[3]
Common side effects include constipation and muscle spasms.[2] Other side effects may include swelling due to fluid retention.[2] While there is no evidence of harm with use in prenancy, such use has not been well studied.[5] It is a monoclonal antibody that binds to and blocks calcitonin gene-related peptide receptor (CGRPR).[2]
Erenumab was approved for medical use in the United States and Europe in 2018.[3][4] In the United Kingdom it costs about £390 every 4 weeks as of 2021.[2] This amount in the United States is about 630 USD.[6]
References[edit]
- ^ a b "Erenumab (Aimovig) Use During Pregnancy". Drugs.com. 17 April 2019. Archived from the original on 29 November 2020. Retrieved 5 May 2020.
- ^ a b c d e f BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 498. ISBN 978-0857114105.
- ^ a b c d "Erenumab-aooe Monograph for Professionals". Drugs.com. Archived from the original on 3 March 2021. Retrieved 15 December 2021.
- ^ a b "Aimovig". Archived from the original on 17 October 2020. Retrieved 15 December 2021.
- ^ "Erenumab (Aimovig) Use During Pregnancy". Drugs.com. Archived from the original on 29 November 2020. Retrieved 15 December 2021.
- ^ "Aimovig Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 11 January 2022. Retrieved 15 December 2021.